An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

NCT00730171 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1743

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Constipation
Chronic Constipation

Interventions

DRUG: Linaclotide

Sponsor

Ironwood Pharmaceuticals, Inc.

Collaborators

[object Object]